Pancreatic Cancer Research

ResearcherNational Health Research Institutes, TaiwanNo recent work listed

Shang-Hung Chen

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers
0
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
2
Papers, trials and grants by year

2021: 1 trial

Trials 1

  1. A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pa… Principal investigator NCT05026905↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yung-Yeh Su · 1 shared trial, 2021 · strength 0.33
  2. Li-Tzong Chen · 1 shared trial, 2021 · strength 0.33

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.